AR
NVO

Apeiron RIA’s Novo Nordisk NVO Stock Holding History

Apeiron RIA’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,935
Closed -$510K – 213
2024
Q4 		$510K Buy
5,935
+1,199
+25% +$130K 0.14% 120
2024
Q3 		$564K Buy
4,736
+56
+1% +$7.47K 0.16% 108
2024
Q2 		$668K Sell
4,680
-36
-0.8% -$4.77K 0.2% 87
2024
Q1 		$606K Sell
4,716
-198
-4% -$23.6K 0.18% 100
2023
Q4 		$508K Buy
4,914
+128
+3% +$12.7K 0.16% 106
2023
Q3 		$435K Buy
4,786
+58
+1% +$5.11K 0.15% 107
2023
Q2 		$382K Buy
4,728
+316
+7% +$25.8K 0.13% 118
2023
Q1 		$351K Sell
4,412
-1,368
-24% -$97K 0.12% 125
2022
Q4 		$391K Buy
5,780
+58
+1% +$3.4K 0.15% 107
2022
Q3 		$299K Buy
+5,722
New +$307K 0.14% 124
2022
Q2 		– Sell
-3,288
Closed -$200K – 183
2022
Q1 		$200K Buy
+3,288
New +$169K 0.1% 148

Other funds holding NVO

Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Fayez Sarofim & Co
Fayez Sarofim & Co Houston, Texas $39.1B AUM 15.14% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $5.64B AUM 47.16% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
TIM
Thornburg Investment Management Santa Fe, New Mexico $9.63B AUM 35.65% 1-Year Est. Return

Apeiron RIA's NVO Position: Q1 2025 in Review

Apeiron RIA sold out of Novo Nordisk (NVO) in Q1 2025, closing a stake of 5,935 shares — an estimated $510K sold.

Apeiron RIA first reported a position in NVO in Q1 2022 and held it in 11 quarters. The position peaked at $668K in Q2 2024. 1,528 funds tracked by Wall St. Rank hold NVO as of Q1 2025.

  • Apeiron RIA reported no remaining Novo Nordisk position as of Q1 2025 after selling out during the quarter.
  • Apeiron RIA sold 5,935 Novo Nordisk shares in Q1 2025, an estimated $510K.
  • Apeiron RIA first reported a position in Novo Nordisk in Q1 2022 and held it in 11 quarters.
  • Apeiron RIA's Novo Nordisk position peaked at $668K in Q2 2024.
  • 1,528 funds tracked by Wall St. Rank held Novo Nordisk as of Q1 2025.

Based on Apeiron RIA's 13F filing for Q1 2025, filed 29 May 2025.